InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-43.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by MCGOVERN MARK E, Director. Officer active across 1 company, notably Esperion Therapeutics, Inc.. In total, 2 filings have been published. History available since 27 May 2021. The latest transaction was filed on 27 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
12,376 shares0Common StockSEC:0001628280-21-011360:0
12,376 shares0Common StockSEC:0001628280-21-011360
2 of 2 declarations
About MCGOVERN MARK E
Mark E. McGovern serves as a Director at Esperion Therapeutics, Inc. In this role, he contributes to the company's strategy and governance. His expertise in the biopharmaceutical sector is an asset to the board.
